Structural basis of potent Zika–dengue virus antibody cross-neutralization

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nature

• Publication date

  2016-08-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature18938PMID 27626374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Status of vaccine research and development of vaccines for dengue.

  2016cited by this paper
• Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

  2016cited by this paper
• The 3.8 Å resolution cryo-EM structure of Zika virus

  2016cited by this paper
• Structural basis of potent Zika–dengue virus antibody cross-neutralization

  2016cited by this paper
• Structure of the thermally stable Zika virus

  2016cited by this paper
• Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody.

  2016cited by this paper
• The 3.8 angstrom resolution cryo-EM structure of Zika virus.

  2016cited by this paper
• Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host.

  2015cited by this paper
• Recognition determinants of broadly neutralizing human antibodies against dengue viruses

  2015cited by this paper
• Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination

  2014cited by this paper
• A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

  2014cited by this paper
• Mechanism and Significance of Cell Type-Dependent Neutralization of Flaviviruses

  2014cited by this paper
• SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information

  2014cited by this paper
• Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

  2014cited by this paper
• Combined Effects of the Structural Heterogeneity and Dynamics of Flaviviruses on Antibody Recognition

  2014cited by this paper
• The Fc Region of an Antibody Impacts the Neutralization of West Nile Viruses in Different Maturation States

  2013cited by this paper
• Dissection of Antibody Specificities Induced by Yellow Fever Vaccination

  2013cited by this paper
• Functional and evolutionary insight from the crystal structure of rubella virus protein E1

  2013cited by this paper
• How good are my data and what is the resolution?

  2013cited by this paper
• Membrane curvature in flaviviruses.

  2013cited by this paper
• CryoEM structure of the mature dengue virus at 3.5-Å resolution

  2012cited by this paper
• Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.

  2012cited by this paper
• A Summary of

  2011cited by this paper
• Overview of the CCP4 suite and current developments

  2011cited by this paper
• High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells

  2011cited by this paper
• Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms

  2011cited by this paper
• Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres

  2011cited by this paper
• Efficient method for production of high yields of Fab fragments in Drosophila S2 cells.

  2010cited by this paper
• A new bioinformatics analysis tools framework at EMBL–EBI

  2010cited by this paper
• New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.

  2010cited by this paper
• Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

  2010cited by this paper
• The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

  2010cited by this paper
• Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody

  2009cited by this paper
• Clustal W and Clustal X version 2.0

  2007cited by this paper
• Phaser crystallographic software

  2007cited by this paper
• Inference of macromolecular assemblies from crystalline state.

  2007cited by this paper
• Fc receptor but not complement binding is important in antibody protection against HIV

  2007cited by this paper
• Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

  2007cited by this paper
• Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites

  2006cited by this paper
• Structure of West Nile Virus

  2003cited by this paper
• research papers Acta Crystallographica Section D Biological

  2003cited by this paper
• ESPript: analysis of multiple sequence alignments in PostScript

  1999cited by this paper
• Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera.

  1989cited by this paper
• In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody.

  1979cited by this paper

• Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations

  2026influential citation
• EMoMiS: A pipeline for epitope-based molecular mimicry search in protein structures with potential applications to SARS-CoV-2

  2026cites this paper
• A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity

  2025cites this paper
• Profile of the B cell receptor repertoire and antibody responses upon 17DD-YF vaccine boosting

  2025cites this paper
• Development and Immunogenicity Assessment of a Multi-Epitope Antigen Against Zika Virus: An In Silico and In Vivo Approach

  2025cites this paper
• Therapeutic Antibodies for Mosquito‐Borne Orthoflavivirus Infections: Discovery, Engineering Approaches, and Advances in mRNA‐Based Delivery Systems

  2025cites this paper
• The Evolving Role of Zika Virus Envelope Protein in Viral Entry and Pathogenesis

  2025cites this paper
• Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease.

  2025cites this paper
• The Sweet Aspects of Orthoflavivirus Treatment Design and Vaccine Development

  2025cites this paper
• Ultrapotent human antibodies lock E protein dimers central region of diverse DENV3 morphological variants

  2025cites this paper
• A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection

  2025cites this paper
• A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage

  2025cites this paper
• The modified mRNA vaccine protects immunocompromised AG129 mice from lethal challenge and multi-tissue infection by Zika virus

  2025cites this paper
• Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk

  2025cites this paper
• Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine

  2025cites this paper
• Protective envelope dimer epitope-like antibodies are elicited against dengue virus in children after infection and vaccination.

  2025cites this paper
• Zika virus-specific and orthoflavivirus-cross-reactive IgGs correlate with Zika virus seroneutralization depending on prior dengue virus infection

  2025cites this paper
• The Entry of Zika Virus into the Cells and Its Implication for Antiviral Therapy

  2025cites this paper
• Design of Hyperglycosylated Zika Virus E Proteins that Focus Antibody Recognition on the Complex E Dimer Epitope.

  2025cites this paper
• Toward a deeper understanding of dengue: novel method for quantification and isolation of envelope protein epitope-specific antibodies

  2025cites this paper
• From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity

  2025cites this paper
• Identification of a conserved cryptic epitope with cross-immunoreactivity in outer membrane protein K (OmpK) from Vibrio species.

  2025cites this paper
• Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Humans and Colocated Macaques in Thailand and Cambodia

  2025cites this paper
• Seroprevalence of dengue, Zika, and chikungunya in São Sebastião, Brazil (2020–2021): a population-based survey

  2025cites this paper
• Zika virus-like particle production in a stirred tank bioreactor using a baculovirus/insect cell system

  2025cites this paper
• Optimizing Humoral Immunity for Durable and Broad Protection in Flavivirus Vaccines

  2025cites this paper
• pr-independent biogenesis of infectious mature Zika virus particles

  2024cites this paper
• Zika virus T-cell based 704/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodies

  2024cites this paper
• Envelope Protein-Targeting Zika Virus Entry Inhibitors

  2024cites this paper
• Comparison of Three Chimeric Zika Vaccine Prototypes Developed on the Genetic Background of the Clinically Proven Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2

  2024cites this paper
• Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control

  2024cites this paper
• FLAVIVIRUS CROSS-REACTIVITY: INSIGHTS INTO E-PROTEIN CONSERVANCY, PRE-EXISTING IMMUNITY, AND CO-INFECTION

  2024cites this paper
• Algal extracellular polymeric substance compositions drive the binding characteristics, affinity, and phytotoxicity of graphene oxide in water.

  2024cites this paper
• Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase

  2024cites this paper
• Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis

  2024influential citation
• Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies

  2024cites this paper
• Dengue.

  2024cites this paper
• Analysis of Memory Antibody Responses in Individuals with Zika-Associated Guillain–Barré Syndrome

  2024cites this paper
• Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity

  2024cites this paper
• The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2

  2024cites this paper
• A Poly Aptamer Encoded DNA Nanocatcher Informs Efficient Virus Trapping.

  2024cites this paper
• Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection

  2024cites this paper
• Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection

  2024cites this paper
• Prevalence of Powassan Virus Seropositivity Among People with History of Lyme Disease and Non-Lyme Community Controls in the Northeastern United States

  2024cites this paper
• Characterization of Two Highly Specific Monoclonal Antibodies Targeting the Glycan Loop of the Zika Virus Envelope Protein

  2024cites this paper
• An Update on Zika Virus Vaccine Development and New Research Approaches

  2024cites this paper
• Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus

  2024cites this paper
• In vitro enhancement of Zika virus infection by preexisting West Nile virus antibodies in human plasma-derived immunoglobulins revealed after P2 binding site-specific enrichment

  2024cites this paper
• Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

  2024cites this paper
• Continuing development of vaccines and monoclonal antibodies against Zika virus

  2024cites this paper
• The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies

  2023influential citation
• Dengue determinants: Necessities and challenges for universal dengue vaccine development

  2023cites this paper
• Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses

  2023cites this paper
• Prior flavivirus immunity skews the yellow fever vaccine response to expand cross-reactive antibodies with increased risk of antibody dependent enhancement of Zika and dengue virus infection

  2023cites this paper
• Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody

  2023cites this paper
• Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick‐borne encephalitis and dengue virus infections

  2023cites this paper
• Defining the impact of flavivirus envelope protein glycosylation on sensitivity to broadly neutralizing antibodies

  2023cites this paper
• Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement

  2023cites this paper
• Evolution of a Functionally Intact but Antigenically Distinct DENV Fusion Loop

  2023cites this paper
• Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19

  2023cites this paper
• Impact of prior dengue virus infection on Zika virus infection during pregnancy in marmosets

  2023cites this paper
• Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes

  2023influential citation
• New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E

  2023cites this paper
• Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

  2023cites this paper
• Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses

  2023cites this paper
• Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.

  2023cites this paper
• Chapter 2b: The molecular and antigenic structure of TBEV

  2023cites this paper
• Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis.

  2023cites this paper
• Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions

  2023cites this paper
• Nanobodies Selectively Binding to the Idiotype of a Dengue Virus Neutralizing Antibody Do Not Necessarily Mimic the Viral Epitope

  2023cites this paper
• Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses

  2023influential citation
• Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development

  2023cites this paper
• Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue.

  2023cites this paper
• Recombinant Protein Mimicking the Antigenic Structure of the Viral Surface Envelope Protein Reinforces Induction of an Antigen-Specific and Virus-Neutralizing Immune Response Against Dengue Virus

  2023cites this paper
• Extracellular vesicles from Zika virus‐infected cells display viral E protein that binds ZIKV‐neutralizing antibodies to prevent infection enhancement

  2023cites this paper
• Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance

  2023cites this paper
• Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells

  2023cites this paper
• Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report

  2023cites this paper
• The effect of single mutations in Zika virus envelope on escape from broadly neutralizing antibodies

  2023cites this paper
• Integrated control strategies for dengue, Zika, and Chikungunya virus infections.

  2023cites this paper
• Dengue, West Nile, and Zika Viruses: Potential Novel Antiviral Biologics Drugs Currently at Discovery and Preclinical Development Stages

  2022influential citation
• Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness

  2022cites this paper
• Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage.

  2022cites this paper
• Pathogenicity and Structural Basis of Zika Variants with Glycan Loop Deletions in the Envelope Protein

  2022cites this paper
• Enhanced Zika virus‐like particle development using Baculovirus spp. constructs

  2022cites this paper
• Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E.

  2022cites this paper
• Zika Virus (ZIKV): A New Perspective on the Nanomechanical and Structural Properties

  2022cites this paper
• Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses.

  2022cites this paper
• Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function

  2022cites this paper
• A pH-dependent cluster of charges in a conserved cryptic pocket on flaviviral envelopes

  2022cites this paper
• New broad-spectrum anti-Flavivirus human antibodies with Zika virus-neutralizing potential

  2022cites this paper
• New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing Potential

  2022cites this paper
• Comodulation of Dengue and Chikungunya Virus Infection During a Coinfection Scenario in Human Cell Lines

  2022cites this paper
• Zika Virus Vaccine: The Current State of Affairs and Challenges Posed by Antibody-Dependent Enhancement Reaction

  2022cites this paper
• Complementary Effects of Virus Population Are Required for Efficient Virus Infection

  2022cites this paper
• Epitope-Analyzer: A structure-based webtool to analyze broadly neutralizing epitopes

  2022cites this paper
• A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection

  2022cites this paper
• Impact of structural dynamics on biological functions of flaviviruses

  2022cites this paper
• Seroprevalence of Zika virus in pregnant women from central Thailand

  2021cites this paper
• Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production

  2021cites this paper